Warrants - Schedule of Changes in Warrants Outstanding (Details) - Warrants - USD ($) $ / shares in Units, shares in Thousands |
6 Months Ended | 12 Months Ended |
|---|---|---|
Jun. 30, 2026 |
Dec. 31, 2025 |
|
| Number of Shares (in thousands) | ||
| Beginning balance (in shares) | 583 | |
| Granted (in shares) | 0 | |
| Exercised (in shares) | (578) | |
| Ending balance (in shares) | 5 | 583 |
| Weighted- Average Exercise Price | ||
| Beginning balance (in USD per share) | $ 7.55 | |
| Granted (in USD per share) | 0 | |
| Exercised (in USD per share) | 7.57 | |
| Ending balance (in USD per share) | $ 5.55 | $ 7.55 |
| Additional Disclosures | ||
| Weighted average remaining contractual term (in years) | 7 days | 4 years |
| Aggregate intrinsic value, beginning balance | $ 219,000 | |
| Aggregate intrinsic value, ending balance | $ 27,000 | $ 219,000 |
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments outstanding intrinsic value. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments exercises in period weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Share Based Compensation Arrangements By Share Based Payment Award Non Option Equity Instruments Grants In Period Weighted Average Exercise Price No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average remaining contractual term. No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Details
|